We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.s financial performance into perspective.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 30, 2010 | 10.40 | 10.53 | 10.25 | 10.25 | 236,937 |
| Aug 31, 2010 | 10.25 | 10.55 | 10.22 | 10.25 | 515,996 |
| Sep 1, 2010 | 10.37 | 10.55 | 10.32 | 10.41 | 503,151 |
The historical stock information provided is for informational purposes only and is not intended for trading purposes. The historical stock information is provided by Mergent, a third party service, and Enzon Pharmaceuticals Inc. does not maintain or provide information directly to this service. Prices display split-adjusted cost basis per share on that date.
| (ENZN) NASDAQ | |
| Last Trade | 10.580 |
| Change(%) |
0.17
|
| Volume | 208,700 |
| Sep 2, 2010 4:00 PM ET | |
Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.
News
Details on upcoming events are not yet available.
click here to be notified of all upcoming events.


Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.
Company continues to progress as an innovative oncology
development company
--Company is transformed to be exclusively focused on its pipeline--
